国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Clinical Study of Obesity (Siman-E-Mufrat) and Comparative Therapeutic Evaluation of Darchini and Safoof-E-Muhazzil in Its Management

Ziaur Rahman , Siddiqui MY , Muhammad Mohsin and Mursaleen Naseer

Obesity (Siman-e-Mufrat) is nowadays becoming a challenging threat to clinician worldwide. Its prevalence is rapidly increasing. It is usually associated with other comorbidities such as Diabetes mellitus, Hypertension, Atherosclerosis,Cardiovascular and Cerebrovascular disease. There are various drugs in modern medicine that are used to treat obesity but having adverse effect so it is need of time to find out a drug from the system of Unani medicine with no adverse effect or minimal side effect. For this purpose A Randomized single blind study was designed to comparative clinical trial of Darchini and Safoof-e-Muhazzil for evaluation of efficacy of Darchini in comparison of Safoof-e-Muhazzil on obesity. Study was conducted in the Department of Moalejat, A.K.T.C Hospital. The protocol therapy duration was 90 days and follow up fortnightly. Cases are divided into two groups, test group (Group A), control group (Group B) comprising 30 patients in each group. Assessment of efficacy was done on the basis of objective parameters.The result of present clinical trial demonstrates that Safoof-e-Darchini is equally effective in comparison of Safoof-e-Muhazzil. Safoof-e-Muhazzil is also showing its effect on mild to moderate obesity like Darchini but both are ineffective in morbid obesity.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。